For research use only. Not for therapeutic Use.
ZM 306416(Cat No.:I004594)is a selective inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), which plays a critical role in angiogenesis, the process of new blood vessel formation that supports tumor growth and metastasis. By blocking VEGFR2 activity, ZM 306416 disrupts signaling pathways essential for vascular development, reducing tumor blood supply and inhibiting cancer progression. It has shown promise in preclinical models of cancer, particularly in targeting solid tumors that rely on angiogenesis. ZM 306416 is a valuable tool for studying VEGFR2-related processes and potential anti-angiogenic cancer therapies.
Catalog Number | I004594 |
CAS Number | 690206-97-4 |
Synonyms | N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine |
Molecular Formula | C16H13ClFN3O2 |
Purity | ≥95% |
Target | Src |
Solubility | DMSO: 67 mg/mL, H2O: < 1 mg/mL |
Storage | 3 years -20C powder |
IC50 | 0.67uM(VEGFR); 0.33±0.08uM(Src); 1.3±0.2 μM(Abl) |
IUPAC Name | N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine |
InChI | InChI=1S/C16H13ClFN3O2/c1-22-14-6-10-13(7-15(14)23-2)19-8-20-16(10)21-12-4-3-9(17)5-11(12)18/h3-8H,1-2H3,(H,19,20,21) |
InChIKey | YHUIUSRCUKUUQA-UHFFFAOYSA-N |
SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Cl)F)OC |
Reference | <p style=/line-height:25px/> |